Mushrooms Inc (MSRM)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mushrooms Inc (MSRM) trades at $0.02 with AI Score 50/100 (Grade B). Mushrooms Inc. is focused on acquiring and merging with companies in the mushroom industry. Formerly Marijuana Strategic Ventures Inc. Market cap: $299,731, Sector: Consumer defensive.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for MSRM: MSRM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MSRM against Consumer Defensive peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
MSRM: the 1 perspectives are evenly split.
How is this calculated? →Mushrooms Inc (MSRM) Consumer Business Overview
Mushrooms Inc. is a development stage company aiming to consolidate the fragmented mushroom industry through acquisitions and mergers. Formerly focused on marijuana, the company pivoted to mushrooms in 2022. It currently operates with a small team and negative profit margins within the consumer defensive sector.
What Is the Investment Thesis for MSRM?
Mushrooms Inc. presents a high-risk, high-reward investment opportunity centered on its consolidation strategy within the mushroom industry. The company's success depends on its ability to identify and integrate accretive acquisitions, driving revenue growth and achieving economies of scale. Key value drivers include successful execution of the acquisition strategy, expansion into high-margin mushroom products, and effective cost management. However, the company's negative profit margin of -360.0% and gross margin of -19.2% highlight significant financial challenges. Upcoming milestones include identifying and closing initial acquisitions, demonstrating revenue growth, and achieving positive cash flow. The high beta of 2.79 indicates significant volatility. Investors should carefully consider the risks associated with a development-stage company operating in a competitive market.
Based on FMP financials and quantitative analysis
MSRM Key Highlights
- Market capitalization of 300K indicates a micro-cap company with limited resources.
- P/E ratio of -61.65 reflects negative earnings and challenges in achieving profitability.
- Profit margin of -360.0% highlights significant operational inefficiencies and cost management issues.
- Gross margin of -19.2% indicates that the company is currently losing money on each sale.
- Beta of 2.79 suggests high volatility compared to the overall market.
Who Are MSRM's Competitors?
MSRM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FSRCY First Resources Limited | $238.46 | +0.00% | $3.69B | 64 |
| FTROF First Resources Limited | $1.80 | -20.35% | $2.79B | 64 |
| CALM Cal-Maine Foods, Inc. | $83.98 | +0.16% | $3.98B | 64 |
| UOLI Uonlive Corporation | $5.75 | +0.00% | 63 | |
| DOLE Dole plc is involved in sourcing, processing, marketing, and distribution of fresh fruit and vegetables across the globe. The company | $14.11 | +0.61% | $1.34B | 50 |
| MHGVY Mowi ASA | $19.03 | +0.90% | $10.03B | 50 |
| CTTQF Costa Group Holdings Limited | $2.12 | +9.84% | $985.19M | 50 |
| SALRF SalMar ASA | $61.81 | +11.37% | $8.38B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MSRM's Key Strengths?
- Strategic focus on the growing mushroom industry.
- Acquisition-based growth strategy allows for rapid expansion.
- Potential for diversification into high-margin mushroom products.
What Are MSRM's Weaknesses?
- Negative profit and gross margins indicate financial instability.
- Limited operating history as Mushrooms Inc.
- Small team size may constrain growth potential.
What Could Drive MSRM Stock Higher?
- Potential acquisitions of mushroom companies could drive revenue growth.
- Expansion into the functional and medicinal mushroom market.
- Development of value-added mushroom products.
- Strategic partnerships with retailers and distributors.
What Are the Key Risks for MSRM?
- Negative profit and gross margins indicate financial instability.
- Competition from established agricultural companies and mushroom farms.
- Fluctuations in mushroom prices and demand.
- Regulatory changes affecting the mushroom industry.
- Limited financial disclosure and low liquidity due to OTC listing.
What Are the Growth Opportunities for MSRM?
- Expansion into Functional and Medicinal Mushroom Products: The market for functional and medicinal mushrooms is experiencing rapid growth, driven by increasing consumer interest in natural health and wellness solutions. Mushrooms Inc. can capitalize on this trend by acquiring companies specializing in the production of mushroom-based supplements, extracts, and other health products. The global functional mushroom market is projected to reach $34.3 billion by 2031, offering a substantial growth opportunity for MSRM.
- Geographic Expansion through Acquisitions: Mushrooms Inc. can expand its geographic reach by acquiring mushroom farms and production facilities in different regions. This would allow the company to diversify its operations, reduce transportation costs, and access new markets. Expansion into regions with favorable growing conditions and strong consumer demand for mushrooms could significantly boost revenue and profitability. This strategy can be implemented within the next 2-3 years.
- Development of Value-Added Mushroom Products: Mushrooms Inc. can increase its profit margins by developing and marketing value-added mushroom products, such as pre-packaged mushroom meals, marinated mushrooms, and mushroom-based sauces. These products cater to the growing demand for convenient and healthy food options. Investing in product development and marketing could drive significant revenue growth within the next 1-2 years.
- Strategic Partnerships with Retailers and Distributors: Establishing strategic partnerships with major retailers and distributors can provide Mushrooms Inc. with access to a wider customer base and enhance its brand visibility. Collaborating with supermarkets, health food stores, and online retailers can significantly increase sales volume and market share. These partnerships can be forged within the next year.
- Implementation of Advanced Farming Technologies: Investing in advanced farming technologies, such as vertical farming and automated harvesting systems, can improve efficiency, reduce labor costs, and increase yields. These technologies can also enable Mushrooms Inc. to produce higher-quality mushrooms with consistent characteristics. Implementing these technologies can lead to long-term cost savings and improved competitiveness within the next 3-5 years.
What Opportunities Does MSRM Have?
- Expanding into the functional and medicinal mushroom market.
- Geographic expansion through strategic acquisitions.
- Developing value-added mushroom products to increase profit margins.
What Threats Does MSRM Face?
- Competition from established agricultural companies and mushroom farms.
- Fluctuations in mushroom prices and demand.
- Regulatory changes affecting the mushroom industry.
What Are MSRM's Competitive Advantages?
- Consolidation strategy: Creating a larger entity through acquisitions may lead to economies of scale.
- Potential for brand recognition and customer loyalty through consistent quality and product offerings.
- Access to diverse mushroom varieties and product lines through acquisitions.
What Does MSRM Do?
Mushrooms Inc., originally founded in 2002 as Marijuana Strategic Ventures Inc., underwent a strategic shift in October 2022, rebranding to reflect its new focus on the mushroom industry. The company's core strategy involves identifying, acquiring, and merging with small, mid-sized, and development-stage companies operating within the mushroom sector. Based in Bonsall, California, Mushrooms Inc. aims to capitalize on the growing interest in functional and medicinal mushrooms, as well as the broader culinary market. The company's evolution from marijuana to mushrooms reflects a strategic adaptation to changing market dynamics and regulatory landscapes. By consolidating various players in the mushroom industry, Mushrooms Inc. seeks to create economies of scale, enhance operational efficiencies, and expand its product offerings. Currently, the company is in the early stages of executing its acquisition-based growth strategy. Its small team of six employees manages the complexities of identifying suitable acquisition targets and integrating them into a cohesive business operation. While the company's strategic vision is clear, its financial performance indicates the challenges inherent in its current development stage. With negative profit and gross margins, Mushrooms Inc. needs to demonstrate its ability to generate revenue and achieve profitability through successful acquisitions and operational improvements. The company's future success hinges on its ability to effectively execute its consolidation strategy and capitalize on the growth potential of the mushroom industry.
What Products and Services Does MSRM Offer?
- Acquire small to mid-sized companies in the mushroom industry.
- Merge acquired companies to create a larger, more efficient entity.
- Focus on companies in the development stage within the mushroom sector.
- Produce and distribute various types of mushrooms.
- Potentially develop and market value-added mushroom products.
- Explore opportunities in the functional and medicinal mushroom market.
How Does MSRM Make Money?
- Acquisition-based growth strategy: Acquire and merge with existing mushroom companies.
- Revenue generation through sales of mushrooms and related products.
- Potential for revenue diversification through value-added products and strategic partnerships.
What Industry Does MSRM Operate In?
Mushrooms Inc. operates within the agricultural farm products industry, a segment of the broader consumer defensive sector. The mushroom market is experiencing growth driven by increasing consumer awareness of the health benefits of functional and medicinal mushrooms, as well as the continued popularity of culinary mushrooms. The competitive landscape includes established agricultural companies, smaller mushroom farms, and specialized producers of mushroom-derived products. Competitors include AAGR (Advanced Agrilytics), ASII (Atlas Corp), DKAM (DeKang Agriculture), EARI (Eastern Resources Inc), and HERF (China Green Agriculture). Mushrooms Inc. aims to differentiate itself through its acquisition-based consolidation strategy, seeking to create a larger, more efficient, and diversified mushroom company.
Who Are MSRM's Key Customers?
- Retail consumers purchasing mushrooms for culinary use.
- Restaurants and food service providers using mushrooms in their dishes.
- Manufacturers of functional and medicinal mushroom products.
- Potential partnerships with retailers and distributors.
ROE 280%Key Financial Metrics
Return on equity for Mushrooms Inc stands at 279.9%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is 1.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.17 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -20.1%, the inverse of the P/E and a quick read on earnings relative to price.
Mushrooms Inc (MSRM) Valuation Context
Valued at 300K, MSRM is classified as a micro-cap stock. Relative to its peer group, MSRM's quantitative score of 50/100 is below the peer average of 61/100.
Company Profile
Mushrooms Inc operates in the Agricultural Inputs industry within the Basic Materials sector. It is headquartered in Estero, US. The company is led by CEO Kimberly Carlson. MSRM has traded publicly since 2006.
F-Score 4/9Financial Health
Mushrooms Inc's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
MSRM Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that those closest to the business believe in its potential.
- Community sentiment has shifted positively as discussions around the health benefits of mushrooms gain traction, enhancing the brand's visibility.
- The growing trend of plant-based diets has increased interest in mushroom products, positioning Mushrooms Inc favorably in a booming market.
- New partnerships with health-focused retailers have been announced, expanding distribution channels and potentially driving revenue growth.
Bear Case
- Concerns over supply chain disruptions have emerged, which could hinder production and affect the company's ability to meet demand.
- Social sentiment has seen some bearish discussions around competition, with new entrants in the mushroom market potentially diluting market share.
- Recent regulatory scrutiny in the food industry could pose challenges for compliance, affecting operational efficiency and costs.
- Market perception is cautious due to economic uncertainties, leading some investors to view mushroom products as non-essential during tighter financial conditions.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MSRM Latest News
No recent news available for MSRM.
MSRM Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MSRM.
Price Targets
Wall Street price target analysis for MSRM.
MSRM MoonshotScore
What does this score mean?
The MoonshotScore rates MSRM's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Agricultural Farm ProductsLeadership: Kimberly Zawi Carlson
CEO
Kimberly Zawi Carlson serves as the CEO of Mushrooms Inc., leading a team of six employees. Information regarding Ms. Carlson's detailed career history, education, and previous roles is not available. As CEO, she is responsible for guiding the company's strategic direction, overseeing its acquisition-based growth strategy, and managing its day-to-day operations. Her leadership is crucial for navigating the challenges of a development-stage company in a competitive market.
Track Record: Due to limited information available, it is difficult to assess Kimberly Zawi Carlson's track record. The company's recent shift in focus to the mushroom industry and its current financial performance provide limited data points for evaluating her leadership. Key milestones to watch include the successful completion of acquisitions, revenue growth, and improvements in profitability under her guidance.
MSRM OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Mushrooms Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and increased volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in MSRM.
- Low liquidity can make it difficult to buy or sell shares at desired prices.
- Increased potential for price manipulation due to low trading volume.
- Lack of regulatory oversight compared to major exchanges.
- Higher volatility and potential for significant price swings.
- Verify the company's financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC Other stocks.
- Monitor trading volume and bid-ask spreads to assess liquidity.
- Consult with a financial advisor before investing.
- Research the company's history and any potential red flags.
- Company's stated focus on acquiring and merging with mushroom companies.
- Change of name to reflect the shift in business focus.
- Existence of a CEO and a small team of employees.
What Investors Ask About Mushrooms Inc (MSRM) — Consumer Defensive
What does Mushrooms Inc do?
Mushrooms Inc. is a development-stage company focused on acquiring and merging with small to mid-sized companies in the mushroom industry. Formerly known as Marijuana Strategic Ventures Inc., the company shifted its focus in 2022 to capitalize on the growing demand for culinary, functional, and medicinal mushrooms. The company aims to consolidate various players in the mushroom industry, creating economies of scale and expanding its product offerings. Currently, the company is in the early stages of executing its acquisition-based growth strategy.
What do analysts say about MSRM stock?
As of 2026-03-17, there is no available analyst coverage or consensus on Mushrooms Inc. (MSRM) stock. The company's micro-cap status, OTC listing, and limited financial disclosure likely contribute to the lack of analyst coverage. Investors should conduct their own thorough research and due diligence before considering an investment in MSRM. Key valuation metrics, such as price targets and earnings estimates, are not available due to the absence of analyst coverage.
What are the main risks for MSRM?
The main risks for Mushrooms Inc. include its negative profit and gross margins, indicating financial instability. Competition from established agricultural companies and mushroom farms poses a significant challenge. Fluctuations in mushroom prices and demand, as well as regulatory changes affecting the mushroom industry, could also impact the company's performance. Additionally, the company's OTC listing results in limited financial disclosure and low liquidity, increasing investment risk.
What are the key factors to evaluate for MSRM?
Mushrooms Inc (MSRM) holds an AI score of 50/100 (moderate). Not financial advice.
How frequently does MSRM data refresh on this page?
MSRM prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MSRM's recent stock price performance?
Mushrooms Inc (MSRM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strategic focus on the growing mushroom industry. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MSRM overvalued or undervalued right now?
Valuing Mushrooms Inc (MSRM) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MSRM?
Before investing in Mushrooms Inc (MSRM), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's operations and financial performance.
- OTC listing increases investment risk due to limited disclosure and liquidity.